Log in

Backlash against Johnson & Johnson's COVID-19 vaccine is real and risky — here's how to make its rollout a success

By Tinglong Dai, Johns Hopkins University School of Nursing; Christopher S. Tang, University of California, Los Angeles, and Ho-Yin Mak, University of Oxford
Posted 3/5/21

THE CONVERSATION) — More than 50 million Americans have received at least one dose of either the Pfizer or Moderna COVID-19 vaccine. So far, Americans have been largely brand-agnostic, but that's …

This item is available in full to subscribers.

Please log in to continue

Log in


X
X